aspergillosis 中文意思是什麼
aspergillosis
解釋
n. 名詞 【醫學】麴黴病,麴菌病。-
In conclusion, treatment with amphotericin b and itraconazole has negligible efficacy in cns aspergillosis
結論:聯用兩性黴素b和伊曲康唑治療cns麴黴病無明顯療效。 -
Nursing to 20 pulmonary aspergillosis patients
20例肺麴黴菌感染病人的護理 -
Diagnostic techniques for avian aspergillosis
禽麴黴菌病診斷技術 -
Combination therapy was used as primary therapy for invasive aspergillosis in 47 %, and as salvage in 80 %
47 %的侵襲性麴黴菌感染患者採用聯合治療作為首選, 80 %的患者作為補救治療。 -
The value of serum galactomannan detection for diagnosis of invasive aspergillosis in hematopoietic stem cell transplant recipients
異基因造血幹細胞移植治療再生障礙性貧血16例臨床觀察 -
We sought to determine the approach to antifungal prophylaxis, and diagnostic and therapeutic practices for the management of invasive aspergillosis in liver transplant recipients
我們在此探尋肝移植受者侵襲性麴黴菌感染的預防、診斷以及治療。 -
Disseminated invasive aspergillosis is a serious and potentially lethal infectious complication of immunosuppressed individuals, including transplant recipients
對于包含器官移植受者在內的免疫抑制個體,彌漫性侵襲麴黴菌感染是致命的感染性並發癥。 -
The rate of response to posaconazole was higher among patients with extrapulmonary aspergillosis ( 53 % ) than among those with pulmonary aspergillosis ( 39 % ), the results indicate
泊沙康唑對肺外麴黴菌病患者療效( 53 % )高於肺內麴黴菌病患者療效( 39 % ) ,研究結果表明。 -
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients : a prospective, multicenter, observational study
背景:聯合應用伏立康唑和卡泊芬凈作為器官移植患者侵襲性麴黴感染的基礎性治療方法的療效尚未進行研究。 -
Posaconazole has significant in vitro activity against a wide range of fungi, including aspergillus species, the authors explain, but little is known about its clinical effectiveness and safety in patients with invasive aspergillosis
泊沙康唑在體外實驗中對多種真菌有拮抗作用,包括麴黴菌屬,該文章作者解釋道,但其對侵襲性麴黴菌病患者的臨床療效及安全性尚不清楚。 -
New york ( reuters health ) dec 29 - posaconazole is an effective alternative for patients with invasive aspergillosis refractory to conventional therapy, according to a report in the january 1, 2007 clinical infectious diseases
紐約(路透社健康專欄) 12月29日?據《臨床感染疾病》上2007年1月1日一篇文章稱,泊沙康唑對傳統藥物難治的侵襲性麴黴菌病有效,可作為一種治療選擇。
分享友人